Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

EU Regulators Will Not Appeal Qualcomm Ruling

-Reuters
byBenzinga Newsdesk
September 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

-Reuters

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Tevogen Bio Entered Into A Securities Purchase Agreement With An Investor Pursuant To Which The Investor Agreed To Purchase Shares Of Series A Preferred Stock Of The Company For An Aggregate Purchase Price Of $8M

By Benzinga Newsdesk
February 15, 10:26 AM
On February 14, 2024, Tevogen Bio Holdings Inc. (the "Company") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology,

TVGN